SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novacare (NOV) breaking out...
NOV 15.67+0.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Baker who wrote (335)10/9/1998 6:22:00 PM
From: simarx  Read Replies (1) of 420
 
NOVACARE INC. (NYSE: NOV)

Novacare was recently downgraded and took a plunge from 10 + to the recent lows in the 2's. The company is grossly undervalued and does not deserve to be at these levels. In fact, we have been watching NOV's Level 2 Box and the prints. There appears to be great buy pressure and it is growing.

Summary of current fundamentals

Book Value approximately $9! (It is trading at 2 1/2)!

Market Cap is $136.8 Mil while the company has sales of $1.67 Billion

LOW P/E of 2.37

We believe the downgrade and earnings news from the company is already built into the price (Look at the chart.) This company is grossly under-valued.

This is a speculative buy recommendation but the fundamentals suggest that the company is low risk long-term and a good possibility for a short-term percentage gain.

Current bid is 2 1/2

Good fortune to all.

Related Yahoo Finance Link on Novacare:
biz.yahoo.com

Source: investoralley.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext